Insulin pens for treatment of diabetes;Insulinpens in der diabetesbehandlung

Therapeutische Umschau

Volumn 63, Issue 6, 2006, Pages 398-404

  Bärtsch Kohli, Ursula ^a   Comtesse, Ch ^a   Wetekam, B ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMINSULIN BASAL; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN; NOVO RAPID; RECOMBINANT HUMAN INSULIN;

DEVICE; DIABETES MELLITUS; INJECTION; INSULIN TREATMENT; NEEDLE; PATIENT ATTITUDE; PATIENT INFORMATION; REVIEW;

DIABETES MELLITUS; DOSAGE FORMS; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT DESIGN; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33745448472     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.63.6.398     Document Type: Review

References (17)

1. Schaad P. Steigflug bei Ypsomed hält an. Der Bund, Mittwoch 16. November 2005.
2. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004; 26: 1498-505.
3. Korytkowski M, Bell D, Jacobsen C, Suwannasari R, Flex-Pen Study Team. A multicenter, randomised, open-label, comparative, two-period crossover trial of preference, efficacy and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003; 25: 2836-48.
4. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr 2004; 43: 69-74.
5. Puder JJ, Atar M, Muller B, Pavan M, Keller U. Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diabetes Res Clin Pract 2005; 67: 119-23.
6. Jehle PM, Micheler C. Jehle DR, Breitig D, Boehm BO. Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens. Lancet 1999; 354: 1604-7.
7. Look D, Strauss K. Nadeln mehrfach verwenden? Diabetes Journal 1998; 10: 31-4.
8. Raile K, Noelle V, Landgraf R, Schwartz HP. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with with type 1 diabetes. Exp Clin Endocrinol Diabetes 2001; 109: 393-6.
9. Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes 1996; 104: 106-10.
10. Villiers de FPR. Lipohypertrophy - a complication of insulin injections. S Afr Med J 2005; 95: 858-9.
11. Thow JC, Johnson AB, Marsden S, Taylor R, Home PD. Morphology of palpable injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med 1990; 7: 795-9.
12. Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care 1984; 7: 479-80.
13. Roper NA, Bilous RW. Resolution of lipohypertrophy following change of shortacting insulin to insulin lispro (humalog). Diabet Med 1998; 15: 1063-4.
14. Reach G, Cahane M, Vias M, Papoz L, Forhan A, Guillemin C. HbA1c in children attending summer camps organized by L'Aide aux Jeunes Diabetiques: Evidence for a harmful effect of lipohypertrophies in the early years of diabetes. Diabete Metabolisme 1993; 19(1 Pt 2): 195-201.
15. Chowdhury TA, Escudier V. Poor glycemic control caused by insulin induces liphypertrophy. BMJ 2003; 327: 383-4.
16. Rogar NA, Bilous RW. Revolution of lipohypertrophy following change of short acting insulin to insulin lispro. Dibet Med 1998; 15: 1063-4.
17. Wallymahmed ME, Littler P, Clegg C, Haqqani MT, Macfarlane IA. Nodules of fibrocollagenous scart tissue induced by subcutaneous insulin injections: a cause of poor diabetic control. Postgrad Med J 2004; 80: 732-3.